RIVM seeks dialogue with Industry for safe and green chemistry RIVM would like to explore possibilities to eliminate obstacles during innovation of green chemistry with industry.
European research into chemical mixtures launched EU project EuroMix (European Test and Risk Assessment Strategies for Mixtures) was launched recently.
Cost-effective risk assessment of nanomaterials may be feasible Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.
More children subjected to CT scanning The number of medical examinations in which children are exposed to relatively high radiation doses has increased significantly over the last years.
Nanotechnology in the fight against cancer Nanotechnology offers improved options for the diagnosis and treatment of cancer.
Tracking down sources of disease outbreaks like Sherlock Holmes. 'I want to know the story behind an epidemic'. Interview with Jaap van Dissel, Director of RIVM Centre for Infectious Disease Control.
Cervical cancer screening in the Netherlands January 19 - 25 European Cervical Cancer Prevention Week.
State of infectious diseases in The Netherlands RIVM report 'State of Infectious Diseases 2012' provides insight into the development of infectious diseases in The Netherlands.
Jaap van Dissel appointed as Director of the RIVM Centre for Infectious Disease Control Prof Jaap van Dissel is appointed as Director of the RIVM Centre for Infectious Disease Control. He takes up the post on 15 August and succeeds Prof.
Extra measles vaccinations for risk groups Some areas of the Netherlands where families for religious reasons chose not to get their babies vaccinated are now reporting cases of measles, and it is expected that the number of cases will incr